top of page
AdobeStock_299345803.jpeg

The Jones Foundation
Board of Directors

team images9.png

Robert W. Jones, Chairman

Robert W. Jones, a seasoned finance professional, currently serves as a Senior Advisor and former Vice Chairman of Investment Banking at the prestigious firm, Morgan Stanley. His extensive experience encompasses roles in both the public sector and with not-for-profit organizations, serving on various boards. Academically, he holds a degree from Colgate University and an MBA from the renowned Harvard Business School. Robert and his spouse reside in the town of Bedford, New York.

team images6.png

Robert J. Kheel, JD, Vice President

Robert J. Kheel is the proud parent of the fifth child born through the Jones Institute's in vitro fertilization program. He was a partner at the law firm Willkie Farr & Gallagher LLP for over four decades and continues to be actively involved in mediation and arbitration. Kheel also serves as a director and officer for multiple nonprofit organizations, including the Howard and Georgeanna Jones Foundation for Reproductive Medicine.

team images.png

David H. Brockway, Treasurer

David Brockway retired as a tax partner with the British law firm of Linklaters LLP. His career spanned more than 40 years focusing on corporate tax planning with a particular emphasis on international tax matters. David is a former chief of staff of the Joint Committee on Taxation of the U.S. Congress, serving from l983-l987. In that capacity he had overall responsibility for the activities of the staff in the formulation of congressional tax policy, legislative drafting, and revenue estimating. Mr. Brockway has also served as a member of the Executive Committee of the Tax Section of the New York State Bar Association, the Advisory Board of the American Tax Institute in Europe, the Board of Directors of the National Foreign Trade Council, the Advisory group for the American law Institute Project on Subchapter C, and as a consultant for the American Law Institute Project on Tax Treaties. David is currently a member of the Howard and Georgeanna Jones Foundation for Reproductive Medicine Board of Directors where he serves as Treasurer of the Board of Directors, Chair of the Finance Committee and Chair of the Strategic Planning Task Force. David received his A.B. from Cornell University in l968 and his J.D. from Harvard in l971. He served in the U.S. Army from l963 to l966. He is married to Marilyn and has two adult children

team images3.png

Georgeanna Jones Klingensmith, MD, Secretary

Georgeanna Jones Klingensmith is a Pediatric Professor Emerita at the University of Colorado School of Medicine. She specialized in pediatric endocrinology and served as the Director of Pediatric Diabetes at the Barbara Davis Diabetes Center. Her research focused on enhancing outcomes for children with type 1 diabetes. She received her medical degree from Duke University, completed her pediatric residency at the University of Colorado and Washington University, and obtained a fellowship in pediatric endocrinology at Johns Hopkins. As a member of the Jones Foundation Board, she is particularly passionate about increasing funding for research to improve in vitro fertilization treatments and their success rates.

team images16.png

Mary F. Davies, President

Mary F. Davies is President of the Howard and Georgeanna Jones Foundation for Reproductive Medicine. She has served as President of the Foundation for 21 years, and as a member of the Board of Directors for 35 years, having held the positions of Vice Chairman, Chairman of the Executive Committee, Chairman of the Development Committee and Chair of three major special events including the Eastern Virginia Medical School (EVMS) Jones Institute Building Dedication in l992. In addition to her commitments to the Jones Foundation, Ms. Davies served as a member of the Advancement Committee of the Board of Visitors of EVMS and a member of the Development Committee of the EVMS Foundation. Ms. Davies was also Vice President of Institutional Advancement at Cape Heny Collegiate School (CHCS), in Virginia Beach where she had responsibility for development of the independent day school with over 1,000 students in grades pre-kindergarten through twelve. Prior to her employment at Cape Henry, Ms. Davies served as a member of the CHCS Board of Directors for nine years, where she was a member of the Students’ Assistance Foundation, the Executive Committee and Chair of the Development Committee. Prior to joining CHCS Ms. Davies was a Senior Vice President at Bank of America. As a banker Ms. Davies was responsible for marketing and administration of retail retirement plans with a portfolio of over $500 million. She also served as a consultant and director of marketing and legal plans for two regional bank holding companies with departmental assets in excess of $200 million, and as a consultant to three mid-sized commercial banks for planning and implementation of retirement programs and their subsequent relations with broker affiliations. Ms. Davies is a graduate of Sweet Briar College and the University of Colorado Graduate School of Banking. She is the grateful mother of two adult children born as the result of assisted reproductive medical treatments at the Jones Institute of EVMS. Her oldest daughter holds the distinction of being the 287th baby born by in vitro fertilization in the U.S.

team images5.png

Ari Babaknia, MD

Dr. Ari Babaknia Is a Johns Hopkins’ trained Reproductive Endocrinologist who has practiced Medicine in Newport Beach, California for 25 years, as well as serving as a Clinical Associate Professor at the School of Medicine, University of California in Irvine. He received his Doctorate of Medicine at the University of Tehran. Dr. Babaknia is one of the pioneers of minimally invasive surgery and usage of laser beams in medicine since early 1980’s. In addition to publishing more than 50 research and clinical articles on women’s health and wellness in peer reviewed journals, he is the author and co-author of over dozen books in the field of women’s health. He is the recipient of the National Medical Research Award for excellence in medical research from the American College of Obstetricians and Gynecologists. Dr. Babaknia has been a patron of arts and literature for many years. He is the Founder and Executive Director of Persian Heritage Foundation (1987-2007), as well as member of the Board of Directors of several other scientific, charity and cultural Foundations. His latest contribution in directing a team of researchers on Holocaust studies for the past 20 years, culminated in publication of a 4-volume book about the Holocaust and other genocides of the last one hundred years, in Farsi. Dr Babaknia has served as the Chairman of the Institute for the Holocaust Studies in Washington D.C. (2011-2013), as well as the Chairman of the Holocaust Remembrance Day of the Orange County, California Jewish Federation (1993-2013).

team images11.png

Susan L. Crockin, JD

Susan Crockin, JD has been working in the legal, ethical, and policy fields surrounding assisted reproductive technologies (ART) since 1988, when she established one of the first adoption and ART legal practices. She currently serves as an adjunct professor at Georgetown University Law Center, where she teaches ART Law courses that she developed. Additionally, she is a senior scholar at the university's O'Neill Center for National & Global Health Law and a faculty affiliate at the Kennedy Institute of Ethics. Crockin has authored or co-authored numerous scholarly articles, a regular column she created called "Legally Speaking," and three books, including "Legal Conceptions: the evolving law and policy of assisted reproductive technologies" co-authored with the late Dr. Howard Jones. Furthermore, she has developed an interdisciplinary curricular program called "Jones Rounds: at the intersection of reproductive medicine law and ethics" through a grant from the Jones Foundation. Crockin is a frequent lecturer on the legal, ethical, and policy aspects of ART, maintains her legal and consulting practice, and is a current member of the Ethics Committee of the American Society of Reproductive Medicine. She received her J.D. from Northeastern University School of Law and her B.A. summa cum laude from Tufts University.

team images2.png

Edythe C. Harrison

Edythe Harison is an American politician who served as a member of the Virginia House of Delegates from 1980 to 1983. In 1974, she played a pivotal role in establishing the Virginia Opera Association and spearheaded a fundraising initiative to restore the Norfolk Municipal Auditorium, which became the new home of the opera company, now known as the Harrison Opera House.

team images8.png

Mark R. Hughes, MD, PhD

Mark Hughes graduated in Biology and Chemistry from St. Johns University followed by a Ph.D. in Molecular Biochemistry at the University of Arizona Medical Center. He continued his training at the Baylor College of Medicine in Houston as a postdoctoral fellow with Bert O’Malley, where his pivotal work was published in Science, Nature, Lancet, NEJM, and involved the cloning of the vitamin D and progesterone receptors and characterization of the first mutations found in human gene transcription factors. Mutations in the “tips” of zinc fingers of the vitamin D receptor were identified in the DNA of patients with rickets. These were the first mutations identified in any human gene transcription factor and led to a lead article in Nature. Following this training Hughes completed his M.D. at Baylor College of Medicine, followed by house staff training in Internal Medicine and clinical subspecialty training at Duke University. He then returned as junior faculty to Baylor’s newly formed Genetics Institute. Among his accomplishments was the realization that single cells could be molecularly data mined for diagnostic advantage: This led to a multi-year collaboration with reproductive endocrinologists and embryologists at the Hammersmith and UCLondon; the field of Preimplantation Genetic Diagnosis was born. In 1993 Hughes' research was recognized by Science magazine as being one of the "ten most significant advances" in all of science that year; spanning all the physical, biological and mathematical sciences for that year. Hughes’ work has centered on understanding gene expression in the early human embryo. His work on embryonic stem cells was acknowledged along with Ian Wilmut (of Dolly the sheep fame) when Hughes was awarded the “Pioneer in Stem Cell Biology” award. Because of federal funding limitations on embryo diagnostics and stem cell science, he founded the Genesis Genetics Institute where, for 14 years these technologies were provided to patients, in concert with some 370 world-wide human reproductive centers. His company operated full Genetic diagnostic laboratories in 12 countries, with two in the UK and eleven in the USA. Genesis Genetics was acquired in 2016 by CooperSurgical. In January 2023 Dr. Hughes retired to his home in Michigan where he remains an active entrepreneur in the biosciences.

team images7.png

Lawrence M. Jones

Lawrence Jones is a financial consultant and the co-founder of the investment and consulting firm Cherry Creek Capital Management, which is based in Denver, Colorado. He and his spouse, Gayle, have three offspring and reside in Denver.

team images4.png

Eric F. Luce, PhD

Dr. Eric F. Luce, a seasoned educator and former associate professor, is the proud parent of a daughter who was an early success story of the renowned Howard and Georgeanna Jones Institute for Reproductive Medicine at Eastern Virginia Medical School. As a member of the Jones Foundation Board, Dr. Luce is committed to upholding the legacy of Drs. Georgeanna and Howard Jones, pioneers in the field of reproductive medicine.

team images14.png

Suheil J. Muasher, MD

Dr. Suheil J. Muasher is a highly respected and accomplished obstetrician and gynecologist. He received his medical education from the American University in Beirut and completed his residency and fellowship training at prestigious institutions, including the Greater Baltimore Medical Center, Johns Hopkins University, and the Jones Institute of Eastern Virginia Medical School. After an extensive 20-year affiliation with the Jones Institute, where he held various leadership roles, he became a Clinical Professor at George Washington University and Johns Hopkins University. In 2012, he joined the Department of Obstetrics and Gynecology at Duke University, where he served as a Professor in the Division of Reproductive Endocrinology and Infertility, as well as the Vice Chair for Education and the Director of Graduate Learning and Academic Development. He is currently a Professor Emeritus of Obstetrics and Gynecology at Duke, reflecting his distinguished career and contributions to the field of women's healthcare.

team images10.png

James H. Segars, Jr. MD

Dr. James Segars is a prominent gynecologist and obstetrician who serves as the Howard and Georgeanna Seegar Jones Professor at Johns Hopkins University. His research has focused on investigating the molecular mechanisms underlying various reproductive diseases, such as uterine fibroids, endometriosis, polycystic ovary syndrome (PCOS), and infertility. Dr. Segars received his education from Duke University and Duke University School of Medicine, and then completed his residency in obstetrics and gynecology, as well as a fellowship in reproductive endocrinology and infertility, at Vanderbilt University. After his clinical training, he spent three years as a postdoctoral scholar at the National Institutes of Health (NIH). For the next 20 years, Dr. Segars worked as a physician-scientist in the intramural program at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) before joining the faculty at Johns Hopkins. At Johns Hopkins, his division is actively involved in several NIH-funded clinical and translational research studies focused on fibroids, endometriosis, and infertility. Throughout his distinguished career, Dr. Segars has published more than 250 research papers and serves on the editorial boards of several academic journals.

team images15.png

Robert J. Stillman, MD

Dr. Stillman is a highly qualified medical professional with expertise in the field of Reproductive Endocrinology and Infertility. He has received extensive education and training, including earning his medical degree from Georgetown University, completing his OB/GYN residency at Duke University, and completing a Reproductive Endocrinology and Infertility fellowship at Harvard Medical School. Prior to joining Shady Grove Fertility, where he served as Medical Director and a Senior Partner for 22 years, he served as a tenured Professor of Obstetrics and Gynecology and Director of the Division of Reproductive Endocrinology and Fertility at George Washington School of Medicine for 18 years. During his career, Dr. Stillman has contributed significantly to the field through his research, speaking engagements, and academic interests. He has published on topics such as in utero DES exposure, the promotion and expansion of eSET, the defense of oocyte donation, and the ethical critique of Uterine Transplantation and Whole Genome Screening. He has also examined the intersection of Assisted Reproductive Technology and the Law. Currently, Dr. Stillman serves as the Medical Director, Emeritus and Senior Mentor at Shady Grove Fertility, and he is the Founder and Managing Member of Fertility Space Consultants, LLC.

team images13.png

James P. Toner, MD, PhD

Jim Toner finished his fellowship at the Jones Institute in 1991 and then became a faculty member there. In 2000, he left to help establish the Atlanta Center for Reproductive Medicine, and in 2019 he returned to academia, joining Emory University as a full Professor. For many years, Dr. Toner has held various leadership positions within SART and ASRM, and he has been instrumental in developing Informed Consents and Infographics to showcase the advancements in IVF in the United States.

team images12.png

Thomas L. Toth, MD

Dr. Toth has been a clinician, scientist, and teacher at Harvard Medical School for over 30 years. He received his undergraduate and medical school training at the University of Missouri-Kansas City School of Medicine in an accelerated combined BA/MD program. He obtained his internship and residency in Obstetrics and Gynecology at the Brigham and Women’s/Massachusetts General Hospitals in Boston. He subsequently obtained his fellowship training in Reproductive Endocrinology and Infertility at the Jones Institute in Norfolk, VA under the mentorship of Drs. Howard and Georgeanna Jones pioneers in in vitro fertilization. Dr. Toth was the founding Director of the Massachusetts General Hospital IVF Unit and founding Director of the Massachusetts General Hospital Reproductive Endocrinology and Infertility Fellowship Training Program. He has served as an elected member in several roles for the American Society of Reproductive Medicine and the Society for Assisted Reproductive Technology. He is the recipient of awards/recognition for his teaching, mentoring, research, and compassionate care. His primary research has focused on understanding the fundamental scientific underpinnings of human oocyte cryopreservation and the translation of this know-how from the bench to bedside. He was a founding member of the 1st World Congress in Human Oocyte Freezing in Bologna, Italy. He continues his passion to democratize IVF with the development of novel automated IVF lab technologies using microfluidics to significantly improve access, reduce cost, and increase reliability. Dr. Toth is currently Associate Program Director of the Reproductive Endocrinology and Infertility Fellowship at Boston IVF and Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center. He is an Associate Professor of Obstetrics, Gynecology, and Reproductive Biology at Harvard Medical School.

AdobeStock_299345803.jpeg

FROM THE BOARD

Empowering Families, Nurturing Hope

Our Unwavering Commitment to Reproductive Wellness


The Jones Foundation is committed to tackling the challenges of infertility and enhancing reproductive health. It achieves this by funding critical research and fostering public and professional dialogues to shape the bioethical landscape of reproductive medicine. The future holds a brighter outlook for infertility treatment, thanks to the dedicated efforts of scientists and physicians who are devoted not only to the application of assisted reproductive technologies, but also to the pursuit of new discoveries that will ultimately enrich the human experience. Many of these individuals are represented on the foundation's various committees and boards listed below.

FROM THE BOARD

Empowering Families, Nurturing Hope

Our Unwavering Commitment to Reproductive Wellness

 

The Jones Foundation is committed to tackling the challenges of infertility and enhancing reproductive health. It achieves this by funding critical research and fostering public and professional dialogues to shape the bioethical landscape of reproductive medicine. The future holds a brighter outlook for infertility treatment, thanks to the dedicated efforts of scientists and physicians who are devoted not only to the application of assisted reproductive technologies, but also to the pursuit of new discoveries that will ultimately enrich the human experience. Many of these individuals are represented on the foundation's various committees and boards listed below.

AdobeStock_623417660.jpeg

Medical Executive Committee

The Medical Executive Committee (MEC) is a strategic advisory group that provides guidance to the Board of Directors of the Foundation (Board) on all medical matters related to reproductive medicine and closely associated fields, such as ethics and education. The MEC is responsible for overseeing the review process of grant applications, prize nominations, and award recommendations, thereby facilitating the final decisions made by the Board. Furthermore, the MEC acts as a bridge between the Medical Advisory Council and the Board.

AdobeStock_171090577.jpeg

Young Professionals Board

Medical Advisory Council

AdobeStock_171090577.jpeg
AdobeStock_623417660.jpeg

Medical Executive Committee

The Medical Executive Committee (MEC) is a strategic advisory group that provides guidance to the Board of Directors of the Foundation (Board) on all medical matters related to reproductive medicine and closely associated fields, such as ethics and education. The MEC is responsible for overseeing the review process of grant applications, prize nominations, and award recommendations, thereby facilitating the final decisions made by the Board. Furthermore, the MEC acts as a bridge between the Medical Advisory Council and the Board.

bottom of page